Hello, and welcome to the S&W Seed Company Fourth Quarter and Fiscal Year 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Robert Blum with Lytham Partners. Please go ahead..

All right. Thank you, and thank you all for joining us today to discuss S&W Seed Company's fourth quarter and fiscal year 2023 financial results for the period ended June 30, 2023.

With us on the call representing the company today are Mark Herrmann, the company's Chief Executive Officer; and Vanessa Baughman, the company's Interim Chief Financial Officer. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session.

Before we begin with prepared remarks, please note that statements made by the management team of S&W Seed Company during the course of this conference call may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended, and such forward-looking statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements describe future expectations, plans, results or strategies and are generally preceded by words such as may, future, plan or planned, will or should, expected, anticipates, draft, eventually or projected.

Listeners are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in the company's 10-K for the fiscal year ended June 30, 2023, and other filings subsequently made by the company with the Securities and Exchange Commission.

In addition, to supplement S&W's financial results reported in accordance with U.S. Generally Accepted Accounting Principles or GAAP, S&W will be discussing adjusted EBITDA on this call.

These non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measure and are not prepared under any comprehensive set of accounting rules or principles.

A description of adjusted EBITDA and reconciliations of historical adjusted EBITDA to net loss are included at the end of S&W's earnings release issued earlier today, which has been posted on the Investor Relations page of S&W's website.

An audio recording and webcast replay for today's conference call will also be available online on the company's Investor Relations page. With that said, let me turn the call over to Mark Herrmann, Chief Executive Officer for S&W Seed Company.

Mark?.

our sorghum technology solutions in its pipeline and forage products. Let me start with sorghum. First off, I think it's critical for everyone to understand just how special and unique, I believe, the Double Team sorghum solution truly is.

Launched on commercial scale in 2022, Double Team controls grassy weeds in sorghum that rob water, nutrients and ultimately, yield from the crop. Prior to 2022, due to the lack of effective weed control options in sorghum, farmers continue to bear higher risk for yield and crop loss due to weed pressure.

Other crops offered options for weed control that ultimately led farmers to those crops, which, in many cases, are less suited for higher temperatures and more restricted water conditions that sorghum is uniquely adapted to. This has been a contributing factor to the historical declines in U.S.

sorghum acres from around 10 million acres to around 6.5 million acres currently. In contrast, corn, soybean and cotton growers have all benefited from research investments in advanced tools for wheat control technologies.

With its limited launch in 2021 and broader commercial launch in calendar year 2022, Double Team grain sorghum now accounts for what we estimate is approximately 6% of all grain sorghum acres in the U.S. We believe this will grow to more than 10% this next year.

This is a tremendous achievement and highlights the value and demand for innovation in this critical crop. This increase in penetration and adoption of Double Team and sorghum is similar to historical penetration trends and technology launches of many of the large-acre crops such as corn, soybeans and cotton.

Double Team for grain sorghum is just the first leg of our planned sorghum technology portfolio stool for fiscal year 2024, as I'm happy to introduce two additional sorghum trait platforms from our R&D pipeline. First, we are introducing our Double Team forage sorghum solution in 2024.

We expect that we will see the same rapid adoption for forage sorghum as we saw for grain sorghum. Early demand has been strong, and we expect it to sell out in its introductory year and continue on a penetration curve similar to what we have already seen with Double Team grain sorghum.

Secondly, we expect to commence a pilot launch of our prussic acid-free trait for sorghum, what we previously called dhurrin-free, with a few thousand acres being planted this year. As a background, dhurrin is a precursor to prussic acid, which is highly toxic to room in animals that feed on fresh sorghum forage.

This, in essence, is what I would define as a quality trait that has great value for risk reduction, enabling safe livestock raising of forage sorghum acres. With the pilot launch this upcoming year, we plan on commercially launching our prussic acid-free trait in 2025.

It will be initially introduced as a solo trait, and then shortly thereafter expected to be provided as a stack trait with Double Team. Let me pause there for a second.

What do I mean by a stack trait? And why is it important? As some of you may know, the biotech seed industry was built on developing new traits that address specific issues from weed control, pest control management above and below ground, quality and others.

The industry has addressed each of these specific issues by providing valuable seed options to farmers through stack trait offerings in a single seed.

For farmers, there's an incremental value being created by each new trait that protects yield, decreases crop risk, increases crop quality and value and saves time to ultimately improve acre productivity. As such, seed companies can deliver increased value to farmers versus forcing them to choose between valuable individual traits.

Through the research investment and productivity, we can increase the value of the seed while production costs typically remain about the same. The result is a margin and profit improvement per bag of seeds sold. That's why we believe trait-related R&D is so important, and the investments S&W has made over the years are beginning to pay off.

On top of our Double Team weed control system and now prussic acid-free quality trait, we are also on plan to develop a second-generation post grass herbicide trait which we plan to launch in 2025. Further, we are in discovery stage for an insect tolerant to resistant traits and broad-spectrum herbicide trait as well.

We are clearly becoming the key technology provider in this critical, nutrient-packed crop. As the fifth largest cereal crop globally, it can be used as a substitute for many grains in the market today.

We are excited about sorghum because it is a crop that is uniquely equipped to handle higher temperatures and drier climates better than many other crops. But as I mentioned, it hasn't benefited from the historic research investments to successfully launch tools to support step change to improve the crop's productivity.

As farmers increasingly recognize the risk reduction with new tools to control grasses and increase crop raising safety technologies, I believe we will see continued share growth in the current sorghum acres as well as an increase in sorghum acres planted on dry land and limited water availability acres moving back to sorghum due to its improved adaptability to these conditions.

From a sales and marketing perspective, we plan to continue to drive sales through our S&W-owned Sorghum Partners brand and aligned with independent seed companies with current market-leading brands in key grain and forage sorghum markets to maximize market penetration through licensing S&W germplasm and/or traits so even where S&W does not have market presence, we will be working with brands that have presence to deliver our technologies to their customers to optimize availability to farmers and adoption.

This will not only be in the United States, but internationally as well. Today, there are approximately 8.7 million acres of sorghum being grown in four key countries, where we have been developing relationships with seed companies with strong germplasm pools and established farmer relationships in Mexico, Argentina, Brazil and Australia.

Our strategy here will be to out-license our germplasm and/or traits with well-established brands in each key sorghum market to reach the global sorghum market and accelerate adoption. Look for more on this to come.

Operationally, we have developed an operational plan for this upcoming year that is intended to challenge all aspects of our organization to improve upon last year, whether it be in production, sales, marketing, or fulfillment to deliver on the promise that our sorghum technology portfolio provides to farmers.

I believe we have worked through many of the bottlenecks that were presented to the company last year in achieving our original goals.

As you likely saw in our press release, it is my expectation that revenue from Double Team sorghum solutions is expected to be $11.5 million to $14 million in sales, representing an increase of 77% to 115% compared to fiscal 2023. With 70% of this margins on Double Team, this is expected to be a big contributor to our bottom line improvement.

When we break this all down, we see fiscal 2024 as being strong for our sorghum operations with the expectation for significant growth going forward. We are in a leadership position today with our trait portfolio. And with the impressive pipeline I just touched on, we plan to maintain leadership of this important crop for many years to come.

Transitioning, let me quickly touch on our international operations and our partnership with Shell before turning it over to Vanessa for a review of the financials. As I mentioned at the beginning, there are no updates I can share with you on the process we are going through to look to unlock value within our international operations.

We will certainly provide an update if and when something may transpire. In the meantime, we are looking to implement many of the same strategies internationally as we are in the U.S. to drive growth and efficiencies in this segment.

We are looking to optimize our production capabilities to drive down the cost of goods sold while developing a sales and marketing approach that highlights the benefit of our forage solutions around the world. While total results are expected to be slightly higher, we do look for growth in our alfalfa and forage resumed business in the years to come.

As had been the case in our international operations for a few years, there are various factors that are largely outside of our control, namely, the geopolitical risk in certain jurisdictions we sell into. That said, we are looking to mitigate those risks, especially when we think about our guidance for the year.

We are placing minimal dependence on the riskiest markets for us to achieve our stated guidance going forward. We certainly hope there could be an upside if certain markets materialize, but are providing what we believe to be a conservative view into this segment. As mentioned, Vanessa will touch on our guidance in detail momentarily.

Vision Bioenergy Oilseeds LLC is the partnership between S&W Seed and Shell for the purpose of developing novel plant genetics for oilseed cover crops as a feedstock, for biofuels, green diesel and SAF, sustainable aviation fuel.

VBO intends to develop Cambelina, where oil and meal can be extracted for future processing biofuels, animal feed and other bioproducts. On the biofuels front, there's not a lot that we can expand on here, except to say the partnership remains on track from what was communicated during the last conference call.

The entity VBO is expected to carry out initial grain production later this calendar year and more than 7,000 acres of Cambelina planted. To this point, the partnership has met or exceeded all cropping acre thresholds originally laid out.

As has been discussed in the past, Shell is expected to buy all the grain that VBO produces through an offtake agreement that is in place.

Vanessa will remind everyone of its impact to the income statement going forward, but I am certainly pleased with the progress being made, and believe this represents a tremendous long-term opportunity for S&W and its shareholders. As I mentioned on the onset, we are striving to become a best-in-class company.

Every organizational decision we make is expected to be data-driven to ensure it will have a positive impact on our customers and our shareholders going forward. We are instilling increased engagement with the finance team and financial analysis with all decisions that impact cost, margin and cash management.

As such, we have implemented a new series of operational initiatives to drive business towards customer satisfaction and profitability in the near term, including improved life cycle management to reduce obsolescence costs and cash management, rationalization of certain low-margin product lines and effective seed treatment strategy, a seed manufacturing cost reduction plan through improved efficiencies that align with best-in-class standards.

Cost controls in the seed industry are key and often the difference between being profitable and not. It is my goal to have best-in-class cost of goods and operating costs going forward. We also made the decision to suspend our continued investment in the stevia germplasm development program.

As we evaluate changes in the sweetener space, options between lead for fermentation processes driven largely by cost. Until we have a food or ingredient partner or commitment or we can entertain a buyer option for a proprietary germplasm and program.

As you will see from our guidance, we are guiding revenue for fiscal 2024 to be between $76 million and $82 million, representing an expected increase of 3% to 12% compared to fiscal 2023 revenue of $73.5 million.

Again, we have tried to take a conservative view into our international operations and believe the pathway to achieving our stated objectives in the U.S. are achievable.

Importantly, on gross margin front, based on the strategies we've discussed and expect a continued growth from our Double Team, we see consolidated gross margins moving from 20% in 2023 to between 24% and 26% in fiscal 2024. Further, we expect operating expenses to remain flat despite growth in revenues.

The result is an approximate $2 million to $5.5 million anticipated improvement in our adjusted EBITDA compared to fiscal 2023. We know there is still work to be done, but feel good about the strategies being implemented to drive continuous growth and improvement across the organization.

Let me now turn it over to Vanessa to review the financials in detail. I will then provide a few final words, and then we can address your questions.

Vanessa?.

Thank you, Mark. Good morning to everyone on the call today. As this is a year-end conference call, I'm going to focus most of my comments on the results for the fiscal year. A breakout of fourth quarter results is included in the press release, and I would be happy to answer specific questions on the fourth quarter numbers where needed.

Starting with revenue. Total revenue for fiscal 2023 was $73.5 million compared to total revenue for fiscal '22 of $71.4 million. The $2.1 million increase in revenue was primarily due to the $4 million increase in Double Team sorghum sales in the U.S.

domestic market; a $4 million increase in nondormant alfalfa sales in the Middle East and North Africa; and a $3.8 million increase in nondormant alfalfa and grain sorghum sales in Latin America.

This was then offset by a $4.3 million decrease in the Australian domestic pasture sale due to flooding and key planting regions that lowered sales expectations in the first half of fiscal 2023; a $3 million decrease in revenue in the Asia region due to logistical delays in international shipping and COVID-related impacts in China during the prior year that affected distributor demand; a $1.7 million decrease in U.S.

domestic alfalfa revenue due to a decline in demand; and finally, a $1 million decrease in non-Double Team sorghum revenue. As Mark mentioned, as we look to fiscal 2024, we are expecting revenue of $76 million to $82 million, representing an expected increase of $2.5 million to $8.5 million compared to fiscal 2023 revenue of $73.5 million.

Breaking this down further, we are anticipating Double Team to be between $11.5 million to $14 million, an increase of 77% to 115% compared to fiscal 2023. There will be some offset to non-Double Team-related sorghum sales as we transition customers to our higher-valued products.

As such, overall sorghum-related revenue is expected to be between $22 million and $23 million in total compared to $18.5 million in fiscal 2023. On the international side, we are expecting revenue to be between $45 million to $50 million compared to $43.6 million in fiscal 2023. And finally, on the U.S.

forage operation, we see revenue of about $9 million compared to $10.8 million last year. Now turning to margins. GAAP gross margins for fiscal 2023 were 19.8% compared to GAAP gross margins of 8.9% in fiscal 2022.

The strong improvement of GAAP gross margin was primarily driven by the increased sales of a higher-margin Double Team sorghum solution in North America, in addition to the favorability of noncash inventory write-down due to improved inventory life cycle management.

Inventory write-downs, or what we've referred to as LCM expenses, during 2023 were $2.8 million compared to $6.4 million in fiscal 2022, where we experienced a higher level of certain lots that had deteriorated in quality and germination rates.

As Mark mentioned, seed life cycle management will continue to be a focus area for us, as we have reduced our product offerings going into 2024 to customers through seed treatment rationalization. Looking to fiscal 2024, we see continued improvement with gross margins.

Inclusive of any LCM charges, margins are expected to be between 24% and 26% compared to the 19.8% we saw in fiscal 2023. Again, the biggest driver here is expected to be the growth in our high-margin Double Team products. Now we will transition to operating expenses.

GAAP operating expenses for fiscal 2023 were $32.5 million compared to $39.2 million in fiscal 2022. The decrease is a result of the company's focus on aligning its cost structure to support its key centers of value, as Mark mentioned at the onset.

Breaking it down further, there was a $2.5 million decrease in research and development expenses, a $2 million decrease in selling, general and administrative expenses and a $1.5 million decrease from a goodwill impairment charge recognized in fiscal 2022 and a $0.7 million decrease in depreciation and amortization.

This level of $32.5 million, which is inclusive of depreciation and amortization, is a level we feel we can maintain in fiscal 2024, even though we see revenue growing. We are intent on driving efficiencies across the entire enterprise.

Betsy Horton mentioned this in the past, but I think it bears reminding that with the creation of the Trigall and VBO partnership, we would be playing an administrative role for both new ventures, handling things such as finance, accounting, HR and IT under a service level agreement established this year.

In our financial statements, these items are presented as services revenue and an offsetting cost in SG&A, which we believe enhances the visibility into our operating expense reduction initiatives. During fiscal 2023, we had approximately $800,000 of service revenue pertaining to our partnership and an offsetting cost of SG&A of the same $800,000.

As we look to fiscal 2024, we expect about $0.6 million in revenue to come from the partnership, which was a similar offset to the cost of SG&A. Now to EBITDA. Adjusted EBITDA for fiscal 2023 was a negative $9.3 million compared to adjusted EBITDA of negative $23.6 million for fiscal 2022, an improvement of $14.3 million.

A full reconciliation is available in the press release. As we look to fiscal 2024, our guidance is a negative adjusted EBITDA of $7.5 million to negative $4 million. This would represent an improvement of approximately $2 million to $5.5 million compared to fiscal 2023.

The biggest anticipated driver here would be the gross profit leverage from Double Team, grain and forage sorghum sales. Finally, on the net income line. GAAP net income for fiscal 2023 was $14.4 million, or $0.34 per basic and diluted share compared to GAAP net loss of $36.4 million, or a negative $0.93 per basic and diluted share for fiscal 2022.

We experienced a gain on the sale of the business interest of $38.2 million related to the establishment of a partnership with Shell and VBO. One final note. As Mark mentioned earlier, we are scheduled to receive a $6 million payment from Shell in February of 2024.

Despite our negative adjusted EBITDA expectation, which translates rather closely to our cash utilization, the payment from Shell is expected to cover any operating cash needs this year.

Beyond fiscal 2024, if we're able to continue the growth in our sorghum technology portfolio and achieve the benefits of the stability and cost containment initiatives across the remaining parts of the organization, it is our thought that we will be in a positive cash flow position in the near future.

Again, I am happy to follow up with any of the details we went through if you should have additional questions. With that, let me turn it back over to Mark..

Thank you, Vanessa. In summary, I hope you take away from this call that we are laser-focused on operating this business with best-in-class practices from top to bottom. We have a significant growth opportunity ahead of us, not only from our Double Team sorghum technology solutions, but our broader sorghum technology portfolio.

Unique opportunities to be the sole technology leader in the crop doesn't come along very often. But when they do, they tend to see rapid adoption and value creation for both customers and shareholders. I simply couldn't be more enthusiastic to be leading this company at this exciting time.

Thank you for your continued support of S&W Seeds, and I look forward to taking your questions.

Operator?.

Thank you. [Operator Instructions] Today's first question comes from Ben Klieve with Lake Street Capital Market. Please go ahead..

All right. Thanks for taking my questions. A few from me this morning. First of all, on Double Team, I'm wondering if you can talk about kind of expectations versus reality in '23 from this product, $6.5 million - is a great year-over-year clip, but relative to the kind of $12 million target that was laid out a few quarters ago certainly felt short.

So, I'm wondering, if you can talk about what went right, what went poorly with Double Team this year, and then how the realities of '23 give you confidence in your expectations for 2024?.

Hi, Ben. Thank you very much for joining this morning, but also for the question. I think it's an excellent place to discuss, because I don't see it at all as a step back or a concern around Double Team itself.

As we look at the launch of Double Team in 2021, it was on very small volumes with, I believe, 23 different distribution points and or customers. And as we looked at the growth going from '21 to '22, it grew to $2.4 million. And then this last year, to your point, Double Team grew from $2.4 million to $6.5 million.

I mean, it's a tremendous growth curve as far as demand.

And what we've seen from the 23 distribution points that trialed, and sold a very small amount in 2021 is their success rate and positive experience, right, with a solid growth curve from every one of those 23 distribution points except for one that actually changed their distribution makeup, which was no longer part of S&W under the same name.

So as far as growers utilizing and trialing it, and then expanding their use, I mean it was just a tremendous success.

I do believe potentially there was a little bit of over-exuberance, looking for farmers to make a significant growth or significant introductory experience without that opportunity to do a trial, experience it on their farm, and then grow from there. But as I look at other traits that, I've been involved with in the launches.

If I look at Double Team, and the growth curve that it's had from introduction, to what we're expecting this coming year of Double Team being on more than 10% of the U.S. sorghum acres. It's definitely demonstrating a positive impact in the market, and I really have very little to no concern about the performance of the product itself.

Being on 6% of the U.S. acres this year, and we're pretty well through the application of first stack over those acres for grass control. And the number of service calls that - we've received, I'd say are very limited versus what I would have expected for a new technology in the market.

But feedback from the field and others has been very, very positive on performance..

Great. That's a helpful color. Thanks, Mark. And - in your prepared comments, Mark you touched on the kind of - movement of legacy non-Double Team sorghum farmers to Double Team variety.

Can you guys talk about on a high level what your expectation is for sorghum that does not have either Double Team or the profit free trade introduced over the next few years? Is that a business that you just think, is going to - just kind of naturally go away, or do you think there's going to be some material level of revenue from non-technology sorghum for the foreseeable future?.

Yes, that's a great question Ben. And I do think it's part of the lifecycle management that both Vanessa and I talk to as well. Because I do believe, as we look at Double Team and its continued growth on overall sorghum acres.

I do believe it will obviously be replacing, one of its growth factors are replacing current sorghum acres that really have a traditional germplasm in place, right, which we also have our entire sorghum business started out as that - at 2021 introduction. Now that product or product line is much lower margin, but I do anticipate that it will shrink.

I believe our share within those non-Double Team acres will, and should remain the same, if not increasing our share amongst those acres, because of a stronger brand position, and distribution with farmers due to the Double Team trade. But I do anticipate non-Double Team acres in sorghum to be a smaller portion of the sorghum market.

And I believe as Vanessa went through our guidance going forward. She did touch on, we do expect a small decrease in non-Double Team, non-prussic acid grain and forage sorghum as these products show superior performance going forward. The positive to us is on the DT sorghum position. It puts the product margin in the above 60% to 70% margin.

In the conventional sorghum market, we're looking at margins closer to that 20% to 25%, right? So it's a great impact for us, as it's moving the product line up to higher value.

But we need to be very smart about, how we manage the non-Double Team market to ensure we don't build supplies based on historical experiences in a market that is likely to be a decreasing size market, right? So I think the key thing you call out there, is we need to maintain our margin on that non-DT market in our presence, but recognize it needs to be with tighter excess inventories, planning on a shrinking market..

Got it. Got it. Very helpful. Last one from me and then I'll get back in queue. You talked about exiting some kind of lower margin, forage crops and seed treatment applications. I'm wondering if you can talk about the level of revenue contribution from these exited business - exited businesses in '23.

And what, if any, revenue contributions from these businesses that you're leaving, is included in your '24 guidance?.

Yes, that's a great question as well.

And I would say as a general practice, a healthy company, we'll look at everything that's lower than our overall average margin and really question, look, are there things that either one, we can address within our own system that's driving costs that can improve its margin position? Or two, is it diluting the overall business and diluting focus to product lines.

That maybe resources could be moved from those, applied to other areas where clearly the growth in the product line, would deliver more results to the company and the shareholders, right? So, I would say this is a standard practice, that I've really been involved with most of my careers.

So, I don't think the focus itself is highly unusual, but we will be evaluating all these product lines. And you're asking the right question, which I don't have direct answers for you as we evaluate these, and we're fairly early in stage with really drilling down on some, and asking the questions. Do we change our focus and redirect resources.

But it is a process we're going to go heavily through, as we move forward in the business..

Okay. Very good. That's directionally very helpful. Very good. Well, best of luck with all these initiatives. And thanks for taking my questions and I'll get back in line..

Okay. Thank you, Ben..

[Operator Instructions] The next question comes from Nelson Obus with Wynnefield Capital. Please go ahead..

Yes. Hi, there. General, yes this call has been more informative and granular than past calls. So I find that very helpful. Just a quick question about R&D for fiscal '24.

Do you expect it to hold even to where it was in fiscal '23?.

Thanks, Nelson. We are looking at relatively flat spending in research. Now some of what we talked about in the call is the exiting of - some of either the product line, or focus areas that we don't see a clear future of driving revenues and margins.

We're exiting, and I'll use the example of stevia, right? So, we've halted research activities with that product, and that's enabled moving those to our sorghum pipeline.

Where with our sorghum pipeline, we've got much more demand as far as the amount of testing requirements due to the depth of the product line, as well as efforts with germplasm transformation processes to introgress trades.

So, there's been a reduction in some areas, Nelson, and then moving those to what we see as really our high-margin drivers, both for the short and for the long-term. But for this year, our discussion is to keep spend very tight, be highly efficient.

And as we're generating cash to Vanessa's point, we'll keep - reevaluating those on how we invest our resources going forward..

When you look at the EBITDA projections you've given us, does that imply a discontinued operation in stevia or those - or there might be some write-downs that -- in other words, getting out of categories, which could trigger a write-down, is that anticipated in the EBITDA projections? Or is that a separate issue to be dealt with when they come up?.

Yes. I'll let Vanessa refer to it..

Yes. There are no anticipated write-downs, Nelson, from any of the product lines that we're pausing at the moment.

The bearing on the income statement is pretty much all driven in OpEx, right? And so as Mark mentioned, just to put some dollars around it, pausing the stevia R&D program is about $300,000 per fiscal year that we're refocusing our efforts in that R&D space. Again, towards our high-value options for farmers going into the near future, and longer term.

So that's about $300,000. But in our OpEx projections, there are no known write-downs of any of the product lines that we're pausing at this moment..

Okay. Got it..

And with that, Nelson, we're also moving the material itself, right? Because we do have a platform of germplasm that has been developed. We're moving it into cold storage as we look at the next step of where we go with the stevia, germplasm and program..

Fine. You're doing a lot of your revenue in the international realm, and you touched on logistical delays in international shipping. It's been my observation that that's caused an enormous number of problems over the years. And I'm just wondering whether I'm right, and whether you're attacking this cost area.

Obviously, we went through a period of constrained capacity, where you really had to be on the ball to avoid accelerated costs. I think that's trended down now, looking at dry cargo costs.

But can you address that issue? Because it really has not been an area that we've excelled then in the past?.

Yes. And international movement of seed is complex in itself. And then I know of recent years with adding some of the geopolitical pressures on top of it, it's been exasperated even further.

So, one of the steps that the Australian team, which leads this started on, is breaking down every single step between an order, and being received by the ordering entity, every single step and looking at the time line for each of the pieces between paperwork, testing, quality, shipping and all the individual pieces.

And looking at trying to build answers to remove complexity in different steps or make sure that there's current activities wherever there can be so it doesn't become the lengthy process that we've had in - to-date, I shouldn't say in the past, but really to-date.

So there's an effort going on with that right now, Nelson, to look at really streamlining process, streamlining steps to improve, how we have fulfillment..

Yes. So a question - I'm sorry, go ahead..

Some of the - I would just say some of the geopolitical issues, I mean, will continue to be a bit of a minefield that we'll try to address as they arise. But anything we can control, we want to make sure we have the most efficient process as possible..

Yes.

I would imagine the comment you made about expenses, holding expenses at $32 million or whatever, that's - I mean, you might be able to do better if you're able to rationalize certain aspects such as logistics, correct Vanessa?.

That would be accurate. And what Mark describing is the order to cash process, right, and every step in between.

As an example, from the moment, particularly in that Middle East, North Africa area of the world, the lead time required between order and delivery is up to four months, right? And that's optimizing the delivery from whether it comes from the U.S. and/or Australia directly.

So as Mark mentioned, we've masked those processes and aligned when orders come in, and the pace of orders to when demand is expected in that four-month period, and including any logistical obstacles in that evaluation, and removing them to the best of our ability.

Post-COVID, at least throughout 2022 and 2023, we were experiencing post-COVID obstacles with regard to getting product in that Middle East and North Africa area of the world. So you heard through our guidance, that we've minimized the sales targets for that region to what we feel is achievable for 2024.

As an example, we talked about obviously the logistic constraints, but the geopolitical environment in Sudan has not subsided, to what we initially thought when we had this call one quarter ago. So, we've adjusted our guidance to include zero sales in the Sudan region, as an example. We continue to monitor it.

And to your point, if there is an opportunity for upside and/or getting product into the country for demand, then we will absolutely capitalize on it. But at this moment in time, for 2024, we pared back the expectation in Sudan to zero and pared back a bit from Saudi Arabia as well.

So, I think all in, when you look at cost containment, outlining processes, and optimizing the supply chain effort into these areas of the country, it's a high focus for that Australia team, as they not only monitor sales growth, but also the cost of doing business in those countries..

Great. So this reduction in LCM is very welcome, from 6.4% to 2.8%. We've had some really nasty surprises towards the end of prior fiscal years with inventory write-down.

Do you think 2.8% is kind of the cost of doing business? Or do you think that can be reduced further?.

Yes.....

We're not the same businesses we were before.

I mean, we....?.

Yes. Yes, it's a great question. And Mark and I experienced 8% of sales is sort of what is the industry norm when you think about row crop. I think we can be better than that. There's been a lot of work done in that life - cycle management space, just even starting in fiscal - early fiscal year 2023 in the crop planning cycle.

And that continues to be refined as we plan for our crop plan for 2024 sales. So, I think we can be better than 8%. We are working towards, a better metric as we lead into crop planning for 2025. But 2.9 seems well within the norm, and manageable for the size of our sales and our crop plans for this year..

I realize sorghum customers can return. Let's hope they like what they get the first time..

Yes..

My last comment, which is probably the most important one. Shareholders have really not been served well by this share dilution that's taken place over the last five years. The shares doubled. Without that doubling of the shares, we probably wouldn't be here now. We'd be in somebody else's hands.

But listening to what you had to say, what I found very encouraging, that the $6 million that will flow from Shell into the company should be enough to keep us cash flow breakeven in fiscal '24. And as we look to '25, we may even get to being cash flow positive.

So, I'm assuming that we may not see any more dilution, and that that would be an important goal of the current management.

Is my thinking correct?.

Yes. Thanks for the question, Nelson. And I don't know if we'd be prepared to talk to it right now, and it's probably heavily future-looking. But I do believe from what Vanessa and I have rolled out of looking at cash neutral this next year.

I do believe in the continued growth of the DT, and prussic acid-free platforms that are already launched as of this year as we look to the future.

And I do think our leadership in technology, and sorghum with the full pipeline, along with the second generation of post-planting grass control, I do believe there's a very positive future for continued growth. And the results of those will likely lead in, to your point, heavy decisions on the go-forward as well..

Well, you're right not to be pinned down, but I've talked to a number of shareholders, and that really has been a sticking point, the extraordinary increase in share count. And I just want you to be aware of that. Thank you. Good call..

Absolutely. Thank you..

Seeing no further questions in the queue. I would now like to hand the call back to management for closing remarks..

Well, thank you very much, MJ, as the operator of the call and helping us initiate this. I also want to thank the entire group for joining, and receiving the information that has been put together as far as S&W's results last year, and how we see moving forward. I look forward to our ongoing discussions, and appreciate you all joining the call.

Thank you..

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect your lines..